课题基金 / 基金详情

Molecular dissection of allergen sensitisation and immunotherapy: direct application to precision medicine in treatment of asthma

Molecular dissection of allergen sensitisation and immunotherapy: direct application to precision medicine in treatment of asthma
过敏原致敏与免疫治疗的分子剖析:精准医学在哮喘治疗中的直接应用
批准号:
nhmrc : 2000773
负责人:
金额:
$127.01万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Ideas Grants
财政年份:
2021
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2021-01-01 至 2024-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Asthma is a major global health burden with huge socioeconomic impact. Most asthmatic patients are allergic. Allergen immunotherapy is the only treatment to alter the natural disease course, but does not work in many treated patients, and robust laboratory biomarkers for patient selection and immune monitoring of treatment success are lacking. Therefore, allergen immunotherapy is not offered to most patients who then rely on medications indefinitely. This research will address these needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金